Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Non Operating Income (2022 - 2025)

Historic Non Operating Income for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $31550.0.

  • 60 Degrees Pharmaceuticals' Non Operating Income rose 8979.73% to $31550.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$339428.0, marking a year-over-year decrease of 18136.23%. This contributed to the annual value of -$347008.0 for FY2024, which is 22364.26% down from last year.
  • According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Non Operating Income is $31550.0, which was up 8979.73% from $13066.0 recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Non Operating Income's 5-year high stood at $349823.0 during Q4 2023, with a 5-year trough of -$414366.0 in Q4 2024.
  • Its 4-year average for Non Operating Income is -$272.09, with a median of $16623.0 in 2024.
  • The largest annual percentage gain for 60 Degrees Pharmaceuticals' Non Operating Income in the last 5 years was 270517.58% (2023), contrasted with its biggest fall of 232225.73% (2023).
  • Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Non Operating Income stood at -$13428.0 in 2022, then skyrocketed by 2705.18% to $349823.0 in 2023, then plummeted by 218.45% to -$414366.0 in 2024, then skyrocketed by 107.61% to $31550.0 in 2025.
  • Its last three reported values are $31550.0 in Q3 2025, $13066.0 for Q2 2025, and $30322.0 during Q1 2025.